BioCardia, Inc. — Director's Dealing 2017

Jan 10, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2017-01-09

Reporting Person: STERTZER SIMON H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-09	Common Stock	P	10000	$0.8228	Acquired	31039310	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1258925	Indirect
Common Stock	5386743	Indirect
Common Stock	4816171	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $0.818 to $0.83 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

F2: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.

F3: These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.

F4: These shares are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such shares.

F5: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are sole members and managers.